The latest closing stock price for Avalo Therapeutics as of November 21, 2024 is 9.65.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -54.49% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 34.46, which is 257.1% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.95, which is 59.1% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.31.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -54.49% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 34.46, which is 257.1% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.95, which is 59.1% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.31.